The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Protalix BioTherapeutics Inc (AMEX: PLX) closed at $1.54 down -2.53% from its previous closing price of $1.58. In other words, the price has decreased by -$2.53 from its previous closing price. On the day, 0.61 million shares were traded. PLX stock price reached its highest trading level at $1.59 during the session, while it also had its lowest trading level at $1.5209.
Ratios:
For a deeper understanding of Protalix BioTherapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.69 and its Current Ratio is at 2.49. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on June 08, 2020, Reiterated its Buy rating but revised its target price to $11 from $3 previously.
On April 17, 2017, Rodman & Renshaw reiterated its Buy rating and also lowered its target price recommendation from $4 to $5.
On April 04, 2016, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $3.50.Rodman & Renshaw initiated its Buy rating on April 04, 2016, with a $3.50 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PLX now has a Market Capitalization of 122594936 and an Enterprise Value of 93087960. As of this moment, Protalix’s Price-to-Earnings (P/E) ratio for their current fiscal year is 36.67, and their Forward P/E ratio for the next fiscal year is 2.39. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.05 while its Price-to-Book (P/B) ratio in mrq is 2.66. Its current Enterprise Value per Revenue stands at 1.558 whereas that against EBITDA is 15.629.
Stock Price History:
The Beta on a monthly basis for PLX is -0.22, which has changed by 0.3050847 over the last 52 weeks, in comparison to a change of 0.11730647 over the same period for the S&P500. Over the past 52 weeks, PLX has reached a high of $3.10, while it has fallen to a 52-week low of $0.82. The 50-Day Moving Average of the stock is -30.90%, while the 200-Day Moving Average is calculated to be -16.48%.
Shares Statistics:
For the past three months, PLX has traded an average of 955.97K shares per day and 691040 over the past ten days. A total of 78.13M shares are outstanding, with a floating share count of 73.81M. Insiders hold about 7.28% of the company’s shares, while institutions hold 11.19% stake in the company. Shares short for PLX as of 1747267200 were 979395 with a Short Ratio of 1.02, compared to 1744675200 on 740272. Therefore, it implies a Short% of Shares Outstanding of 979395 and a Short% of Float of 1.28.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
